Literature DB >> 25225111

Murine models of diastolic dysfunction and heart failure with preserved ejection fraction.

S Horgan1, C Watson2, N Glezeva2, J Baugh2.   

Abstract

Left ventricular diastolic dysfunction leads to heart failure with preserved ejection fraction, an increasingly prevalent condition largely driven by modern day lifestyle risk factors. As heart failure with preserved ejection fraction accounts for almost one-half of all patients with heart failure, appropriate nonhuman animal models are required to improve our understanding of the pathophysiology of this syndrome and to provide a platform for preclinical investigation of potential therapies. Hypertension, obesity, and diabetes are major risk factors for diastolic dysfunction and heart failure with preserved ejection fraction. This review focuses on murine models reflecting this disease continuum driven by the aforementioned common risk factors. We describe various models of diastolic dysfunction and highlight models of heart failure with preserved ejection fraction reported in the literature. Strengths and weaknesses of the different models are discussed to provide an aid to translational scientists when selecting an appropriate model. We also bring attention to the fact that heart failure with preserved ejection fraction is difficult to diagnose in animal models and that, therefore, there is a paucity of well described animal models of this increasingly important condition.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models; diabetes and obesity; diastolic dysfunction; heart failure with preserved ejection fraction (HFpEF); hypertension

Mesh:

Year:  2014        PMID: 25225111     DOI: 10.1016/j.cardfail.2014.09.001

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  30 in total

1.  Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.

Authors:  Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2018-11-29       Impact factor: 2.969

Review 2.  Why Don't We Have Proven Treatments for HFpEF?

Authors:  Jason Roh; Nicholas Houstis; Anthony Rosenzweig
Journal:  Circ Res       Date:  2017-04-14       Impact factor: 17.367

3.  A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II.

Authors:  Jessica A Regan; Adolfo Gabriele Mauro; Salvatore Carbone; Carlo Marchetti; Rabia Gill; Eleonora Mezzaroma; Juan Valle Raleigh; Fadi N Salloum; Benjamin W Van Tassell; Antonio Abbate; Stefano Toldo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

4.  Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.

Authors:  Mark Y Jeong; Ying H Lin; Sara A Wennersten; Kimberly M Demos-Davies; Maria A Cavasin; Jennifer H Mahaffey; Valmen Monzani; Chandrasekhar Saripalli; Paolo Mascagni; T Brett Reece; Amrut V Ambardekar; Henk L Granzier; Charles A Dinarello; Timothy A McKinsey
Journal:  Sci Transl Med       Date:  2018-02-07       Impact factor: 17.956

Review 5.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 6.  ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

Authors:  Timothy D O'Connell; Robert C Block; Shue P Huang; Gregory C Shearer
Journal:  J Mol Cell Cardiol       Date:  2016-12-14       Impact factor: 5.000

7.  EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4.

Authors:  Julie A Eclov; Qingwen Qian; Rebecca Redetzke; Quanhai Chen; Steven C Wu; Chastity L Healy; Steven B Ortmeier; Erin Harmon; Gregory C Shearer; Timothy D O'Connell
Journal:  J Lipid Res       Date:  2015-10-04       Impact factor: 5.922

8.  GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.

Authors:  T Dung Nguyen; Yasushige Shingu; Paulo A Amorim; Christina Schenkl; Michael Schwarzer; Torsten Doenst
Journal:  J Cardiovasc Transl Res       Date:  2018-02-20       Impact factor: 4.132

9.  Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure.

Authors:  Marlene A Wilson; Israel Liberzon; Merry L Lindsey; Yana Lokshina; Victoria B Risbrough; Renu Sah; Susan K Wood; John B Williamson; Francis G Spinale
Journal:  Stress       Date:  2019-06-04       Impact factor: 3.493

10.  Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease.

Authors:  Stephen J Horgan; Chris J Watson; Nadia Glezeva; Pat Collier; Roisin Neary; Isaac J Tea; Niamh Corrigan; Mark Ledwidge; Ken McDonald; John A Baugh
Journal:  J Cardiovasc Transl Res       Date:  2015-11-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.